Article ; Online: Comparing telemedicine to in-person buprenorphine treatment in U.S. veterans with opioid use disorder.
Journal of substance abuse treatment
2021 Volume 133, Page(s) 108492
Abstract: ... national cohort study of veterans diagnosed with opioid use disorder (OUD) receiving buprenorphine ... among patients who received treatment in-person.: Conclusions: Use of telemedicine to deliver buprenorphine ... access to buprenorphine for patients with opioid use disorder (OUD), especially during the COVID-19 ...
| Abstract | Background: Telemedicine-delivered buprenorphine (tele-buprenorphine) can potentially increase access to buprenorphine for patients with opioid use disorder (OUD), especially during the COVID-19 pandemic, but we know little about use in clinical care. Methods: This study was a retrospective national cohort study of veterans diagnosed with opioid use disorder (OUD) receiving buprenorphine treatment from the Veterans Health Administration (VHA) in fiscal years 2012-2019. The study examined trends in use of tele-buprenorphine and compared demographic and clinical characteristics in patients who received tele-buprenorphine versus those who received in-person treatment only. Results: Utilization of tele-buprenorphine increased from 2.29% of buprenorphine patients in FY2012 (n = 187) to 7.96% (n = 1352) in FY2019 in VHA veterans nationally. Compared to patients receiving only in-person care, tele-buprenorphine patients were less likely to be male (AOR = 0.85, 95% CI: 0.73-0.98) or Black (AOR = 0.54, 95% CI: 0.45-0.65). Tele-buprenorphine patients were more likely to be treated in community-based outpatient clinics rather than large medical centers (AOR = 2.91, 95% CI: 2.67-3.17) and to live in rural areas (AOR = 2.12, 95% CI:1.92-2.35). The median days supplied of buprenorphine treatment was 722 (interquartile range: 322-1459) among the tele-buprenorphine patients compared to 295 (interquartile range: 67-854) among patients who received treatment in-person. Conclusions: Use of telemedicine to deliver buprenorphine treatment in VHA increased 3.5-fold between 2012 and 2019, though overall use remained low prior to COVID-19. Tele-buprenorphine is a promising modality especially when treatment access is limited. However, we must continue to understand how practitioners and patient are using telemedicine and how these patients' outcomes compare to those using in-person care. |
|||||
|---|---|---|---|---|---|---|
| MeSH term(s) | Buprenorphine/therapeutic use ; COVID-19 ; Cohort Studies ; Humans ; Male ; Opiate Substitution Treatment ; Opioid-Related Disorders/drug therapy ; Pandemics ; Retrospective Studies ; SARS-CoV-2 ; Telemedicine ; Veterans | |||||
| Chemical Substances | Buprenorphine (40D3SCR4GZ) | |||||
| Language | English | |||||
| Publishing date | 2021-05-28 | |||||
| Publishing country | United States | |||||
| Document type | Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, P.H.S. | |||||
| ZDB-ID | 605923-5 | |||||
| ISSN | 1873-6483 ; 0740-5472 | |||||
| ISSN (online) | 1873-6483 | |||||
| ISSN | 0740-5472 | |||||
| DOI | 10.1016/j.jsat.2021.108492 | |||||
| Shelf mark |
|
|||||
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 2017: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.